Tamás Tábi

18PUBLICATIONS
27CO-AUTHORS
Clinical pharmacology and therapeuticsSpeciation and extinctionToxicology (incl. clinical toxicology)Cellular nervous systemMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 28, 2026
Centrally Acting Skeletal Muscle Relaxants Sharing Molecular Targets with Drugs for Neuropathic Pain Management.

Judit Mária Kirchlechner-Farkas, David Arpad Karadi, Imre Boldizsár

|Nov 13, 2025
Resveratrol Analogs Ameliorate Mitochondrial Impairment and Insulin Resistance in a Streptozotocin-Induced In Vitro Model of Alzheimer's Disease.

Alexandra Paszternák, Kamilla Varga, Ramá Gyöngyössy

|Nov 13, 2025
Crosstalk Between Glycinergic and N-Methyl-D-Aspartate Receptor-Mediated Glutamatergic Transmission in Behaviours Associated with Opioid Use Disorder.

Nariman Essmat, Imre Boldizsár, Yashar Chalabiani

|Jul 29, 2025
Neuroinflammation Based Neurodegenerative In Vitro Model of SH-SY5Y Cells-Differential Effects on Oxidative Stress and Insulin Resistance Relevant to Alzheimer's Pathology.

Csenge Böröczky, Alexandra Paszternák, Rudolf Laufer

|Nov 27, 2024
Resveratrol and Its Derivatives Diminish Lipid Accumulation in Adipocytes In Vitro-Mechanism of Action and Structure-Activity Relationship.

Noémi Sikur, Csenge Böröczky, Alexandra Paszternák

|Oct 26, 2024
Differential Cytoprotective Effect of Resveratrol and Its Derivatives: Focus on Antioxidant and Autophagy-Inducing Effects.

Kamilla Varga, Alexandra Paszternák, Virág Kovács

Pageof 3

Frequent Collaborators

9 joint publications

Éva Szökő

7 joint publications

Mahmoud Al-Khrasani

3 joint publications

Katinka Tarnóczi

3 joint publications

Pál Riba